Mylan’s EpiPen price hike was a scheme to stifle competition, rival claims

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by at-fates-hands on Wednesday April 26, 2017 @09:52AM (#14202907)

This is the beauty and the beast of "Free markets". In most cases, you get what free markets boast about - more competition, reduced pricing, better service.

If you were to look at the statistics, these would either be edge cases or outliers when considering the overwhelming evidence that in most cases, free markets are far better than having burdensome government regulations.

It's funny to hear people complain about how bad the free market system is in this case, but are also crying about employment immigration issues and how we can't get MORE H1-B's visa's, and why SV companies can't bring in more highly skilled candidates from other countries.

It cuts both ways. There is a median in there. Heavily regulated or totally free markets never work, we need to find a balance.

[ Parent | on HN ]

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by maxerickson on Wednesday April 26, 2017 @10:00AM (#14202979)

EpiPen prices occur in a heavily regulated market. Mylan has a patent on the mechanism they sell (no generics from other companies) and there are all sorts of regulations surrounding the production of any drug offered for sale in the US.

[ Parent | on HN ]